newsfilter
← Latest News
GlobeNewswire·

NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company

PITTSBURGH, Oct. 21, 2022 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology platform company Drugging the Genome™ to address disease at the base level